A Case of Extramedullary Plasmacytoma of the Biliary Tract with a Poor Prognosis

Eiko Sakurai1, Kazunori Nakaoka2, Seiji Yamada1

  • 1Department of Diagnostic Pathology, Graduate School of Medicine, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake 470-1192, Japan.

Reports (MDPI)
|July 30, 2025
PubMed

Insights

Extramedullary plasmacytoma (EMP), a rare plasma cell tumor outside bone, can occur in the biliary tract. This case highlights a treatment-resistant biliary EMP in a 76-year-old male, emphasizing diagnostic and management challenges.

Area of Science:

  • Oncology
  • Gastroenterology
  • Pathology

Background:

  • Extramedullary plasmacytoma (EMP) is a rare neoplastic proliferation of monoclonal plasma cells occurring outside the bone marrow.
  • While most EMPs manifest in the head and neck, primary biliary tract involvement is exceptionally rare.

Observation:

  • A 76-year-old male presented with jaundice, leading to the discovery of a biliary tract tumor.
  • Diagnostic imaging revealed a gallbladder and bile duct tumor, confirmed as plasmacytoma via endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and immunohistochemistry.
  • This represents the fifth reported case of primary extramedullary plasmacytoma originating in the biliary tract.

Findings:

  • The patient experienced obstructive jaundice and uncontrolled bile duct infection despite endoscopic biliary drainage.
  • Chemotherapy led to uncontrolled tumor bleeding, necessitating surgical intervention with pancreaticoduodenectomy and cholecystectomy.
  • Despite aggressive treatment, the intrahepatic bile duct tumor progressed, leading to death seven months post-diagnosis due to treatment resistance.

Implications:

  • This case underscores the diagnostic and therapeutic challenges posed by rare biliary tract malignancies like extramedullary plasmacytoma.
  • Effective management strategies for biliary tract EMP require further investigation due to its rarity and aggressive nature.
  • Early diagnosis and novel therapeutic approaches are crucial for improving outcomes in patients with this rare condition.

Related Concept Videos